GLP-1, or glucagon-like peptide-1, is a gut hormone released after eating that helps regulate appetite, insulin secretion, and blood sugar levels
While the overall weight loss with liraglutide is more modest than semaglutide or tirzepatide (typically 8 to 10 percent of body weight), the direct evidence in the postpartum population gives it a clinical credibility that newer medications are still building
In obese individuals without diabetes mellitus, a once-weekly subcutaneous semaglutide (2.4 mg) dose had a significant body weight change compared with a once-daily subcutaneous liraglutide (3.0 mg) dose after 68 weeks
If your child was injured or drowned in an above ground pool accident involving a defective restraining belt, you may be eligible to file a lawsuit
Impure peptide preparations can introduce experimental confounders, as degradation products or synthesis byproducts may have their own biological activities or interfere with receptor binding assays